The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Molecular targets of phytochemicals for cancer prevention
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B. J., Anderson, D. J., Alvarado, R., Ludlam, M. J. C., Stokoe, D., Gloor, S. L., Vigers, G., et al. (2010) · Nature · doi:10.1038/nature08833 · Cited by 1,622
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255
(2008) · Encyclopedia of Genetics, Genomics, Proteomics and Informatics · doi:10.1007/978-1-4020-6754-9_2795 · Cited by 1,243
Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9087-6 · Cited by 1,198
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Engelman, J. A., & Jänne, P. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2248 · Cited by 703
Down-Regulation of the Antitumor Immune Response
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60265-1 · Cited by 682
Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Target profiling of small molecules by chemical proteomics
Rix, U., & Superti-Furga, G. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.216 · Cited by 575
Advances in Homology Protein Structure Modeling
Xiang, Z. (2006) · Current Protein & Peptide Science · doi:10.2174/138920306777452312 · Cited by 479
The art and design of genetic screens: RNA interference
Boutros, M., & Ahringer, J. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2364 · Cited by 474
Virtual screening strategies in drug discovery
McInnes, C. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.08.033 · Cited by 469
Smith, K., Gunaratnam, L., Morley, M., Franovic, A., Mekhail, K., & Lee, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0169 · Cited by 458
Approaches to prevention of epithelial cancer during the preneoplastic period.
Sporn, M. B. (1976) · PubMed · Cited by 445
She, Q., Bode, A. M., Ma, W., Chen, N. Y., & Dong, Z. (2001) · PubMed · Cited by 393
Self-citationShin, D.-S., Kim, H.-N., Shin, K. D., Yoon, Y. J., Kim, S.-J., Han, D. C., & Kwon, B.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2575 · Cited by 309
Jones, H. E., Goddard, L., Gee, J. M. W., Hiscox, S., Rubini, M., Barrow, D., Knowlden, J. M., Williams, S., Wakeling, A. E., & Nicholson, R. I. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00799 · Cited by 297
Smith, J. A., Poteet-Smith, C. E., Xu, Y., Errington, T. M., Hecht, S. M., & Lannigan, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.1027.65.3 · Cited by 284
Ermakova, S. P., Kang, B. S., Choi, B. Y., Choi, H. S., Schuster, T. F., Ma, W.-Y., Bode, A. M., & Dong, Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1586 · Cited by 267
Self-citationUtilizing RNA interference to enhance cancer drug discovery
Iorns, E., Lord, C. J., Turner, N., & Ashworth, A. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2355 · Cited by 251
[6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase
Jeong, C.-H., Bode, A. M., Pugliese, A., Cho, Y.-Y., Kim, H.-G., Shim, J.-H., Jeon, Y.-J., Li, H., Jiang, H., & Dong, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0491 · Cited by 238
Self-citationWeb Services at the European Bioinformatics Institute
Labarga, A., Valentin, F., Anderson, M., & Lopez, R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm291 · Cited by 237
Kang, N. J., Lee, K. W., Shin, B. J., Jung, S. K., Hwang, M. K., Bode, A. M., Heo, Y.-S., Lee, H. J., & Dong, Z. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn282 · Cited by 222
Self-citationRedman, M. W., Tangen, C. M., Goodman, P. J., Lucia, M. S., Coltman, C. A., & Thompson, I. M. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0092 · Cited by 204
Building mammalian signalling pathways with RNAi screens
Moffat, J., & Sabatini, D. M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1860 · Cited by 202
Avis, I., Hong, S. H., Martínez, A., Moody, T., Choi, Y. H., Trepel, J., Das, R., Jett, M., & Mulshine, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0866fje · Cited by 202
Lee, K. W., Kang, N. J., Heo, Y.-S., Rogozin, E. A., Pugliese, A., Hwang, M. K., Bowden, G. T., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3140 · Cited by 194
Self-citationResveratrol directly targets COX‐2 to inhibit carcinogenesis
Zykova, T. A., Zhu, F., Zhai, X., Ma, W., Ermakova, S. P., Lee, K. W., Bode, A. M., & Dong, Z. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20437 · Cited by 191
Self-citationAltered inflammatory responses in leukotriene-deficient mice.
Goulet, J. L., Snouwaert, J. N., Latour, A. M., Coffman, T. M., & Koller, B. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12852 · Cited by 189
Cancer prevention research — then and now
Bode, A. M., & Dong, Z. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2646 · Cited by 188
Self-citationWarshamana-Greene, G. S., Litz, J., Buchdunger, E., García-Echeverría, C., Hofmann, F., & Krystal, G. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1544 · Cited by 184
Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors
Fischmann, T. O., Smith, C. K., Mayhood, T. W., Myers, J. E., Reichert, P., Mannarino, A., Carr, D., Zhu, H., Wong, J., Yang, R.-S., et al. (2009) · Biochemistry · doi:10.1021/bi801898e · Cited by 183
Bode, A. M., Ma, W., Surh, Y., & Dong, Z. (2001) · PubMed · Cited by 170
Self-citationPalermo, C. M., Westlake, C. A., & Gasiewicz, T. A. (2005) · Biochemistry · doi:10.1021/bi047433p · Cited by 166
Myricetin Suppresses UVB-Induced Skin Cancer by Targeting Fyn
Jung, S. K., Lee, K. W., Byun, S., Kang, N. J., Lim, S. H., Heo, Y.-S., Bode, A. M., Bowden, G. T., Lee, H. J., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0899 · Cited by 163
Self-citationMolecular targets for cancer chemoprevention
William, W. N., Heymach, J. V., Kim, E. S., & Lippman, S. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2663 · Cited by 157
Taxanes: an overview of the pharmacokinetics and pharmacodynamics
Vaishampayan, U. N., Parchment, R. E., Jasti, B., & Hussain, M. (1999) · Urology · doi:10.1016/s0090-4295(99)00451-3 · Cited by 149
Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
Lü, H., Chang, D. J., Baratte, B., Meijer, L., & Schulze‐Gahmen, U. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049353p · Cited by 147
Structural Basis for Depletion of Heat Shock Protein 90 Client Proteins by Deguelin
Oh, S. H., Woo, J. K., Yazici, Y. D., Myers, J. N., Kim, W.-Y., Jin, Q., Hong, S., Park, H., Suh, Y., Kim, K.-W., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm007 · Cited by 146
The Intermediate Filament Protein Vimentin Is a New Target for Epigallocatechin Gallate
Ermakova, S. P., Choi, B. Y., Choi, H. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414185200 · Cited by 145
Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity
Lee, K., Lee, K. W., Jung, S. K., Lee, E. J., Heo, Y.-S., Bode, A. M., Lubet, R. A., Lee, H. J., & Dong, Z. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.042 · Cited by 144
Self-citationMyricetin suppresses UVB-induced wrinkle formation and MMP-9 expression by inhibiting Raf
Jung, S. K., Lee, K. W., Kim, H. Y., Oh, M. H., Byun, S., Lim, S. H., Heo, Y.-S., Kang, N. J., Bode, A. M., Dong, Z., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.004 · Cited by 127
Self-citationLuteolin Inhibits Protein Kinase Cϵ and c-Src Activities and UVB-Induced Skin Cancer
Byun, S., Lee, K. W., Jung, S. K., Lee, E. J., Hwang, M. K., Lim, S. H., Bode, A. M., Lee, H. J., & Dong, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4093 · Cited by 125
Self-citationLi, M., He, Z., Ermakova, S. P., Zheng, D., Tang, F., Cho, Y., Zhu, F., Ma, W., Sham, Y. Y., Rogozin, E. A., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0892 · Cited by 123
Self-citationDiscovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
Davies, D. R., Mamat, B., Magnússon, Ó. Þ., Christensen, J., Haraldsson, M. H., Mishra, R. K., Pease, B., Hansen, E., Singh, J., Zembower, D. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900259h · Cited by 122
Lee, K., Hwang, M. K., Lee, D. E., Lee, H. J., & Lee, H. J. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903698s · Cited by 120
Self-citationMyricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1
Lee, K. W., Kang, N. J., Rogozin, E. A., Kim, H.-G., Cho, Y., Bode, A. M., Lee, H. J., Surh, Y., Bowden, G. T., & Dong, Z. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm110 · Cited by 119
Self-citationShim, J., Su, Z., Chae, J., Kim, D. J., Zhu, F., Ma, W., Bode, A. M., Yang, C. S., & Dong, Z. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0185 · Cited by 118
Self-citationShim, J., Choi, H. S., Pugliese, A., Lee, S., Chae, J., Choi, B. Y., Bode, A. M., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802200200 · Cited by 112
Self-citationKwon, J. Y., Lee, K. W., Kim, J., Jung, S. K., Kang, N. J., Hwang, M. K., Heo, Y.-S., Bode, A. M., Dong, Z., & Lee, H. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp216 · Cited by 104
Self-citationOi, N., Jeong, C., Nadas, J., Cho, Y., Pugliese, A., Bode, A. M., & Dong, Z. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2858 · Cited by 100
Self-citationHe, Z., Tang, F., Ermakova, S. P., Li, M., Zhao, Q. J., Cho, Y., Ma, W., Choi, H., Bode, A. M., Yang, C. S., et al. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20299 · Cited by 89
Self-citationMyricetin directly targets JAK1 to inhibit cell transformation
Kumamoto, T., Fujii, M., & Hou, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.027 · Cited by 89
Hwang, M. K., Song, N. R., Kang, N. J., Lee, K. W., & Lee, H. J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.014 · Cited by 84
Self-citationMyricetin inhibits UVB-induced angiogenesis by regulating PI-3 kinase in vivo
Jung, S.-K., Lee, K. W., Byun, S., Lee, E. J., Kim, J. E., Bode, A. M., Dong, Z., & Lee, H. J. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp221 · Cited by 83
Self-citationCocoa Procyanidins Suppress Transformation by Inhibiting Mitogen-activated Protein Kinase Kinase
Kang, N. J., Lee, K. W., Lee, D. E., Rogozin, E. A., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800263200 · Cited by 75
Self-citationKang, N. J., Lee, K. W., Rogozin, E. A., Cho, Y.-Y., Heo, Y.-S., Bode, A. M., Lee, H. J., & Dong, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701459200 · Cited by 71
Molecular Signatures of Lung Cancer — Toward Personalized Therapy
Herbst, R. S., & Lippman, S. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme068218 · Cited by 70
Web services at the European Bioinformatics Institute-2009
McWilliam, H., Valentin, F., Goujon, M., Li, W., Narayanasamy, M., Martin, J., Miyar, T., & López, R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp302 · Cited by 70
Kim, J., Kwon, J. Y., Seo, S. K., Son, J. E., Jung, S. K., Min, S. Y., Hwang, M. K., Heo, Y., Lee, K. W., & Lee, H. J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.008 · Cited by 68
Self-citationA Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity
Cho, Y., Yao, K., Pugliese, A., Malakhova, M. L., Bode, A. M., & Dong, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4959 · Cited by 68
Self-citationCDKs and cyclins in transition(s)
Fisher, R. P. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80106-2 · Cited by 66
Identification and characterization of molecular targets of natural products by mass spectrometry
Cheng, K., Wong, C.-C., Wang, M., He, Q., & Chen, F. (2009) · Mass Spectrometry Reviews · doi:10.1002/mas.20235 · Cited by 65
Hwang, M. K., Kang, N. J., Heo, Y., Lee, K. W., & Lee, H. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.021 · Cited by 64
Self-citationLee, K., Lee, D. E., Seo, S. K., Hwang, M. K., Heo, Y., Lee, H. J., & Lee, H. J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq102 · Cited by 59
Self-citationChemoprevention Meets Glucose Control
Engelman, J. A., & Cantley, L. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0178 · Cited by 58
Phytochemicals in Health and Disease
(2004) · CRC Press eBooks · doi:10.1201/9780203021408 · Cited by 54
Kim, J., Kwon, J. Y., Lee, D. E., Kang, N. J., Heo, Y., Lee, K. W., & Lee, H. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.027 · Cited by 51
Self-citationKang, N. J., Lee, K. W., Kwon, J. Y., Hwang, M. K., Rogozin, E. A., Heo, Y.-S., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0071 · Cited by 51
Self-citationLee, D. E., Lee, K. W., Song, N. R., Seo, S. K., Heo, Y.-S., Kang, N. J., Bode, A. M., Lee, H. J., & Dong, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094797 · Cited by 42
Self-citationOptimization Methods for Virtual Screening on Novel Computational Architectures
Pérez‐Sánchez, H., & Wenzel, W. (2010) · Current Computer - Aided Drug Design · doi:10.2174/157340911793743565 · Cited by 37
Lee, K., Lee, K. W., Byun, S., Jung, S. K., Seo, S. K., Heo, Y.-S., Bode, A. M., Lee, H. J., & Dong, Z. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0137 · Cited by 30
Self-citationLee, K. W., Kang, N. J., Rogozin, E. A., Oh, S., Heo, Y. S., Pugliese, A., Bode, A. M., Lee, H. J., & Dong, Z. (2008) · International Journal of Cancer · doi:10.1002/ijc.23830 · Cited by 24
Self-citationUnprecedented Opportunities and Promise for Cancer Prevention Research
Blackburn, E. H., Tlsty, T. D., & Lippman, S. M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0051 · Cited by 18
The National Program for Cancer Chemotherapy
Zubrod, C. G. (1972) · JAMA · doi:10.1001/jama.1972.03210090041011 · Cited by 12
Beneficial Effects of Resveratrol
Bode, A. M., & Dong, Z. (2004) · Oxidative stress and disease · doi:10.1201/9780203021408.ch13 · Cited by 6
Self-citation
Cited by
Wang, W., Sun, C., Mao, L., Ma, P., Liu, F., Yang, J., & Gao, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.07.004 · Cited by 784
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J., Calani, L., Mena, P., Del Rio, D., & Crozier, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1330-7 · Cited by 602
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Polyphenols and their benefits: A review
Rasouli, H., Farzaei, M. H., & Khodarahmi, R. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2017.1354017 · Cited by 476
Metadata
- Authors
- Lee, K. W., Bode, A. M., & Dong, Z.
- Venue
- Nature Reviews Cancer
- Published
- 2011-02-10
- Volume
- 11
- Issue
- 3
- Pages
- 211-218
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964755431
- Cited by
- 426
- References
- 92
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.